Table 2.

Net league table of major CVD events.

ACEI	1.07 [0.11; 9.97]	0.13 [0.02; 1.21]		1.04 [0.61; 1.77]	0.96 [0.67; 1.37]			5.38 [0.25; 117.25]
1.17 [0.16; 8.60]	ACEI + CCB		0.85 [0.49; 1.46]					3.24 [0.13; 81.31]
0.22 [0.05; 0.96]	0.19 [0.02; 2.27]	ACEI + SPR			3.43 [0.62; 18.84]
0.99 [0.13; 7.84]	0.85 [0.49; 1.46]	4.54 [0.35; 58.37]	ACEI + TZD
1.20 [0.74; 1.96]	1.04 [0.13; 8.10]	5.54 [1.18; 26.05]	1.22 [0.15; 10.24]	ARB	0.71 [0.43; 1.17]	2.64 [1.18; 5.87]	0.81 [0.19; 3.42]
0.96 [0.67; 1.37]	0.82 [0.11; 6.26]	4.41 [0.99; 19.47]	0.97 [0.12; 7.93]	0.80 [0.49; 1.28]	ARB + ACEI
3.19 [1.25; 8.17]	2.73 [0.30; 24.83]	14.62 [2.56; 83.49]	3.22 [0.33; 31.24]	2.64 [1.18; 5.87]	3.31 [1.31; 8.41]	ARB + CCB			1.11 [0.42; 2.93]	1.19 [0.44; 3.24]
0.98 [0.21; 4.49]	0.84 [0.07; 10.34]	4.50 [0.54; 37.19]	1.00 [0.08; 12.90]	0.81 [0.19; 3.42]	1.02 [0.22; 4.64]	0.31 [0.06; 1.60]	ARB + RI
4.54 [0.40; 51.27]	3.89 [0.33; 45.54]	20.83 [1.21; 359.73]	4.59 [0.37; 56.93]	3.76 [0.32; 44.53]	4.72 [0.41; 54.67]	1.43 [0.11; 19.17]	4.64 [0.27; 81.05]	CCB
3.55 [0.91; 13.67]	3.04 [0.27; 33.83]	16.27 [2.22; 119.33]	3.58 [0.30; 42.34]	2.93 [0.84; 10.30]	3.69 [0.97; 14.12]	1.11 [0.42; 2.93]	3.62 [0.54; 24.46]	0.78 [0.05; 12.50]	CCB + BB	1.07 [0.38; 2.99]
3.79 [0.96; 14.98]	3.25 [0.29; 36.65]	17.40 [2.33; 129.87]	3.83 [0.32; 45.86]	3.94 [0.87; 11.30]	3.94 [1.00; 15.48]	1.19 [0.44; 3.24]	3.87 [0.56; 26.60]	0.83 [0.05; 13.52]	1.07 [0.38; 2.99]	CCB + TZD

ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blockers; BB, beta-blocker; CCB, calcium channel blockers; CVD, cardiovascular disease; RI, renin inhibitor; SPR, spironolactone; TZD, thiazide diuretics.

Statistically significant values are expressed in bold.